Approval · Notice of Compliance 13435 · 2012
ULTRAVATE: Notice of Compliance 13435
Issued June 26, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13435
- Date
- June 26, 2012
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of drug substance manufacturing site; Change in the drug substance specifications and analytical procedures
- Therapeutic class
- Topical Corticosteroide
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ULTRAVATE | Not yet assigned | — |
Medicinal ingredients
- HALOBETASOL PROPIONATE 0.5 MG per G